Fundology

ETF · ALPS

0H6M ALPS Medical Breakthroughs ETF

ISIN US00162Q5936London Stock Exchange: 0H6MSS&C Technologies Holdings, Inc.

Latest close

LSE

$57.34

on

Close unchanged since 12/11/2026 — the same price has been reported every trading day since, so this line may not have traded.

Ongoing charge
0.50% a year
Fund size
£135m

As of , at least 15 min delayed

At a glance

As of 20/11/2026, 0H6M (ALPS Medical Breakthroughs ETF, ISIN US00162Q5936) closed at $57.34 on the London Stock Exchange. Its ongoing charge is 0.50% a year (about £50 on £10,000). Over the five years to 20/11/2026 its total return was +28.5%, or +0.8% after UK CPIH inflation.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges. Periods to .
1 year to 20/11/2026
+29.0%
+24.4% after inflation
3 years to 20/11/2026
+137.6%
+114.0% after inflation
5 years to 20/11/2026
+28.5%
+0.8% after inflation

£1,000 put in five years ago would have been worth about £1,285 on 20/11/2026 — about £1,008 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

Risk: volatility and largest fall

How far the price has swung and fallen. The same record as the returns, in pounds.

Volatility (annualised)

40.2%over 1 year

Annualised from weekly returns. Higher means bumpier.

Largest fall, 1 year
−23.2%

How we work it out:Risk figuresFallsVolatilityLargest fall

Charges compared with similar funds

The ongoing charge is taken from the fund’s value every day, so the returns on this page are already after it. Platform and dealing fees are charged separately.
Ongoing charge
0.50%
a year
On £10,000
£50
a year, roughly
Over five years
£248
of £10,000, before growth
Among 30 healthcare funds, share classes counted once
  • 24 charge less
  • 1 the same
  • 4 charge more

Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year. Compared on 21/11/2026, 4 of the 29 other healthcare funds charge more, 1 the same and 24 less (share classes counted once).

As of

A lower charge is not a promise of a higher return: what the fund holds matters more.

As of

Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up

In plain English

ALPS Medical Breakthroughs ETF is an exchange-traded fund (ETF) from ALPS, launched in 2014.

It tracks the S-Network Medical Breakthroughs Index.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Its ongoing charge is 0.5% a year — about £50 a year on every £10,000 invested, taken from the fund's value rather than billed to you.

Income from its investments is paid out to holders as cash.

Healthcare: Pharmaceutical, biotech and medical-equipment companies.

Terms:ETFIndex fundAccumulating or incomeShare classISIN

Key facts

Ticker
0H6M
ISIN
US00162Q5936
Provider
ALPS
Tracks
S-Network Medical Breakthroughs Index
Structure
ETF
An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
Income
Distributing, paid once a year
Income is paid out to holders as cash.
Ongoing charge
0.50% a year · about £50 on £10,000
Fund size
£135m
Launched
Domicile
United States
Currency hedged
No
Price currency
USD
Category
Healthcare

Price chart

Closing price
$57.34+23.0% over 1 year · closing price
0H6M closing price: $46.63 on 21/11/2025, $57.34 on 20/11/2026 (+23.0%); low $46.63, high $68.22.

Over the last year, the closing price went from $46.63 on 21/11/2025 to $57.34 on 20/11/2026 (+23.0%). The lowest close shown was $46.63 on 21/11/2025 and the highest $68.22 on 21/08/2026.

One close a week. Before 18/09/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded. Price only — income paid out is not included, so the line can end below the total return above.

As of , at least 15 min delayed

Five years of prices, and after inflation

55 weekly closes, from 10/12/2021 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.

Create a free account to see the 5-year price chart and the after-inflation chart

Sign-up takes an email address. There is no card to enter and nothing to pay.

How we work it out:Prices and returnsNAV and price

Risk and return in depth

Ratios that weigh return against its ups and downs, every rolling period rather than a few fixed ones, and each large fall with how long it took to recover.
  • Sharpe, Sortino and Calmar ratios

    Sharpe, Sortino and Calmar ratios over 1 year, from weekly returns in pounds.

    With a free account

Create a free account to see the risk ratios

Sign-up takes an email address. There is no card to enter and nothing to pay.

Questions people ask

What is the ongoing charge of 0H6M?

The ongoing charge of 0H6M is 0.50% a year — about £50 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year. Compared on 21/11/2026, 4 of the 29 other healthcare funds charge more, 1 the same and 24 less (share classes counted once).

What does 0H6M track?

0H6M tracks the S-Network Medical Breakthroughs Index.

Is 0H6M accumulating or distributing?

0H6M is distributing: income is paid out to holders as cash. It pays out once a year.

What is the ISIN of 0H6M?

The ISIN of 0H6M is US00162Q5936. An ISIN identifies one exact share class of a fund; 0H6M is its ticker on the London Stock Exchange.

How has 0H6M done after inflation?

Over the five years to 20/11/2026 0H6M’s total return was +28.5%, or +0.8% after UK CPIH inflation. Past performance is not a guide to future returns.

Similar funds

More healthcare funds, largest first. Size is a fact, not a verdict.

Fund documents and methods

Methodology:ReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.